Michelle Dawson posts

Post published on Twitter/X on 3 Oct 2023 11:17

Twitter/X Clinical trial clinicaltrials.gov Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms

1 integrated reply by Michelle Dawson

3 Oct 2023 11:23

Note: included autistics must have "proof of a professional diagnosis of autism OR meet or exceed clinical cut-off on the Social Responsiveness Scale (SRS-2) autism screening instrument"?
Note: one of the 10 secondary outcomes is "Potential Negative Effects of Intervention"

View reply on Twitter/X

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

University of North Carolina, Chapel Hill, University of Virginia, Augusta University, Patient-Centered Outcomes Research Institute (2024). Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic Adults. ClinicalTrials.gov. University of North Carolina, Chapel Hill.

Publication date
17 Jan 2024
Identifier
NCT06060860
Authors
University of North Carolina, Chapel Hill, University of Virginia, Augusta University, Patient-Centered Outcomes Research Institute
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
University of North Carolina, Chapel Hill
Metadata source
clinicaltrials.gov

Abstract

Autistic adults are at a greater risk for mental health problems compared to the general population, with 50% meeting criteria for a co-occurring psychiatric condition. Depression and anxiety are the most common of these conditions among autistic adults, contributing to long-term detrimental effects on health, day-to-day functioning, and quality of life. This study will conduct the first large-scale head-to-head comparison of the two most widely studied mental health interventions for autistic adults: cognitive-behavioral therapy (CBT) and mindfulness-based therapy (MBT). Both interventions are well-established, empirically supported treatments for depression and anxiety in the general population, and both interventions have demonstrated efficacy among autistic adults. However, their comparative effectiveness and heterogeneity of treatment effects have not been established in autistic adults. Both interventions will be delivered by telehealth.